Literature DB >> 19911289

Mortality trends in systemic sclerosis in France and USA, 1980-1998: an age-period-cohort analysis.

Solen Kernéis1, Pierre-Yves Boëlle, Rebecca Freeman Grais, Gérard Pavillon, Eric Jougla, Antoine Flahault, Lone Simonsen, Thomas Hanslik.   

Abstract

We compared trends of Systemic Sclerosis (SS) mortality in France and the USA over the period 1980-1998 and used an Age-Period-Cohort (APC) model to adjust on the age at death of SS patients. All deaths coded with SS as an underlying primary or secondary cause in the national French and US mortality databases from 1980 to 1998 were included in the analysis. SS age-standardized mortality rates increased from 7.2 to 10.3/million in US women (+43%), and from 3 to 3.9/million in French women (+22%). Most of the increase occurred in senior women. In contrast, SS age-standardized death rates remained stable among US men (around 3/million) and French men (around 2/million). In US women, the APC analysis shows a growing cohort effect between 1900 and 1940, tending to stabilize for following cohorts. Similar findings were obtained to a lesser extent in French women. In conclusion, SS mortality rates increased by more than 40% between 1980 and 1998 in the USA, mostly in women born between 1900 and 1940. Whether these trends reflect rising incidence of SS need to be documented. The observed dissimilarity between genders and countries underline that environmental exposure and gender-related factors likely play a major etiological role. Stabilization in the following birth cohorts suggests that the increase of mortality observed since 1980 may slow down in the near future.

Entities:  

Mesh:

Year:  2009        PMID: 19911289     DOI: 10.1007/s10654-009-9403-2

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

Review 1.  Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

Authors:  Clodoveo Ferri; Gabriele Valentini; Franco Cozzi; Marco Sebastiani; Claudio Michelassi; Giovanni La Montagna; Arianna Bullo; Massimiliano Cazzato; Enrico Tirri; Franca Storino; Dilia Giuggioli; Giovanna Cuomo; Mara Rosada; Stefano Bombardieri; Silvano Todesco; Giuseppe Tirri
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

Review 2.  Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.

Authors:  G Spencer-Green; D Alter; H G Welch
Journal:  Am J Med       Date:  1997-09       Impact factor: 4.965

3.  Systemic sclerosis mortality in the United States: 1979-1998.

Authors:  Eswar Krishnan; Daniel E Furst
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Authors:  V D Steen; C V Oddis; C G Conte; J Janoski; G Z Casterline; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-03

5.  Racial differences in scleroderma among women in Michigan.

Authors:  T J Laing; B W Gillespie; M B Toth; M D Mayes; R H Gallavan; C J Burns; J R Johanns; B C Cooper; B J Keroack; M C Wasko; J V Lacey; D Schottenfeld
Journal:  Arthritis Rheum       Date:  1997-04

6.  Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.

Authors:  P J Roberts-Thomson; J G Walker; T Y-T Lu; A Esterman; P Hakendorf; M D Smith; M J Ahern
Journal:  Intern Med J       Date:  2006-08       Impact factor: 2.048

Review 7.  Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.

Authors:  Karen Au; Dinesh Khanna; Philip J Clements; Daniel E Furst; Donald P Tashkin
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 8.  A study of the prevalence of systemic sclerosis in northeast England.

Authors:  R J Allcock; I Forrest; P A Corris; P R Crook; I D Griffiths
Journal:  Rheumatology (Oxford)       Date:  2004-02-10       Impact factor: 7.580

9.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

Authors:  E M Tan; G P Rodnan; I Garcia; Y Moroi; M J Fritzler; C Peebles
Journal:  Arthritis Rheum       Date:  1980-06

10.  Systemic autoimmune disease mortality and occupational exposures.

Authors:  L S Gold; M H Ward; M Dosemeci; A J De Roos
Journal:  Arthritis Rheum       Date:  2007-10
View more
  4 in total

1.  The Generation R Study: design and cohort update 2012.

Authors:  Vincent W V Jaddoe; Cornelia M van Duijn; Oscar H Franco; Albert J van der Heijden; Marinus H van Iizendoorn; Johan C de Jongste; Aad van der Lugt; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2012-10-20       Impact factor: 8.082

2.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

3.  Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA.

Authors:  Pailin Ratanawatkul; Joshua J Solomon; Darlene Kim; Marjorie P George; Lia R Matarrese McGibbon; M Kristen Demoruelle; Mehrnaz Maleki-Fischbach; Isabelle Amigues; Liudmila Kastsianok; Evans R Fernández Pérez
Journal:  ERJ Open Res       Date:  2020-06-15

4.  Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study.

Authors:  Sheraz A Butt; Jørgen L Jeppesen; Christine Fuchs; Mette Mogensen; Merete Engelhart; Christian Torp-Pedersen; Gunnar H Gislason; Søren Jacobsen; Charlotte Andersson
Journal:  BMC Rheumatol       Date:  2018-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.